Search
clemastine (Tavist)
Tradename: Tavist. (clemastine fumarate)
Dosage: 1.34 mg PO BID.
Tabs: 1.34 & 2.68 mg.
Syrup: 0.67 mg/5 mL.
Adverse effects:
-> sedation; less sedating than diphenhydramine, but more sedating than chlorpheniramine
Interactions
drug adverse effects (more general classes)
General
H1 receptor antagonist (antihistamine)
sedative/hypnotic (tranquilizer)
Properties
MISC-INFO: elimination route LIVER
KIDNEY
pregnancy-category B
safety in lactation -
Database Correlations
PUBCHEM correlations
References
- The Pharmacological Basis of Therapeutics, 9th ed.
Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Formulary Update, Kaiser Permanente Northern California,
summer, 2000
Component-of
acetaminophen/clemastine/fumarate/pseudoephedrine
acetaminophen/clemastine/pseudoephedrine
chlorpheniramine/clemastine/pseudoephedrine
clemastine/diphenhydramine/pseudoephedrine
clemastine/phenylpropanolamine